98 related articles for article (PubMed ID: 9811162)
1. First-pass metabolism of peptide drugs in rat perfused liver.
Taki Y; Sakane T; Nadai T; Sezaki H; Amidon GL; Langguth P; Yamashita S
J Pharm Pharmacol; 1998 Sep; 50(9):1013-8. PubMed ID: 9811162
[TBL] [Abstract][Full Text] [Related]
2. Colonic absorption and bioavailability of the pentapeptide metkephamid in the rat.
Langguth P; Breves G; Stöckli A; Merkle HP; Wolffram S
Pharm Res; 1994 Nov; 11(11):1640-5. PubMed ID: 7870683
[TBL] [Abstract][Full Text] [Related]
3. Oral absorption of peptides: the effect of absorption site and enzyme inhibition on the systemic availability of metkephamid.
Langguth P; Merkle HP; Amidon GL
Pharm Res; 1994 Apr; 11(4):528-35. PubMed ID: 8058610
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and transport of the pentapeptide metkephamid by brush-border membrane vesicles of rat intestine.
Langguth P; Bohner V; Biber J; Merkle HP
J Pharm Pharmacol; 1994 Jan; 46(1):34-40. PubMed ID: 8201526
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal absorption of peptide drug: quantitative evaluation of the degradation and the permeation of metkephamid in rat small intestine.
Taki Y; Sakane T; Nadai T; Sezaki H; Amidon GL; Langguth P; Yamashita S
J Pharmacol Exp Ther; 1995 Jul; 274(1):373-7. PubMed ID: 7616421
[TBL] [Abstract][Full Text] [Related]
6. Intestinal absorption of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue. I. Possible factors for the low oral bioavailability in rats.
Sasaki I; Fujita T; Murakami M; Yamamoto A; Nakamura E; Imasaki H; Muranishi S
Biol Pharm Bull; 1994 Sep; 17(9):1256-61. PubMed ID: 7841949
[TBL] [Abstract][Full Text] [Related]
7. Structure-permeation relations of met-enkephalin peptide analogues on absorption and secretion mechanisms in Caco-2 monolayers.
Lang VB; Langguth P; Ottiger C; Wunderli-Allenspach H; Rognan D; Rothen-Rutishauser B; Perriard JC; Lang S; Biber J; Merkle HP
J Pharm Sci; 1997 Jul; 86(7):846-53. PubMed ID: 9232527
[TBL] [Abstract][Full Text] [Related]
8. Intestinal absorption mechanisms of thyrotropin-releasing hormone.
Yokohama S; Yoshioka T; Yamashita K; Kitamori N
J Pharmacobiodyn; 1984 Jul; 7(7):445-51. PubMed ID: 6436461
[TBL] [Abstract][Full Text] [Related]
9. First-pass metabolism of 5-fluorouracil in the perfused rat small intestine.
Gu J; Yuasa H; Hayashi Y; Watanabe J
Biol Pharm Bull; 1998 Aug; 21(8):871-3. PubMed ID: 9743260
[TBL] [Abstract][Full Text] [Related]
10. First-pass elimination. Basic concepts and clinical consequences.
Pond SM; Tozer TN
Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
[TBL] [Abstract][Full Text] [Related]
11. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
Yang SH; Lee MG
Int J Pharm; 2007 Mar; 332(1-2):17-23. PubMed ID: 17157458
[TBL] [Abstract][Full Text] [Related]
12. Cross-tolerance studies distinguish morphine- and metkephamid-induced analgesia.
Hynes MD; Frederickson RC
Life Sci; 1982 Sep 20-27; 31(12-13):1201-4. PubMed ID: 6292609
[TBL] [Abstract][Full Text] [Related]
13. Effect of intestinal first-pass hydrolysis on the oral bioavailability of an ester prodrug of fexofenadine.
Ohura K; Soejima T; Nogata R; Adachi Y; Ninomiya S; Imai T
J Pharm Sci; 2012 Sep; 101(9):3264-74. PubMed ID: 22628163
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability.
Lee JH; Lee MG
J Pharm Pharm Sci; 2007; 10(1):37-50. PubMed ID: 17498392
[TBL] [Abstract][Full Text] [Related]
15. Role of intestinal first-pass metabolism of baicalein in its absorption process.
Zhang L; Lin G; Chang Q; Zuo Z
Pharm Res; 2005 Jul; 22(7):1050-8. PubMed ID: 16028005
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of amitriptyline and one of its metabolites, nortriptyline, in rats: little contribution of considerable hepatic first-pass effect to low bioavailability of amitriptyline due to great intestinal first-pass effect.
Bae SK; Yang KH; Aryal DK; Kim YG; Lee MG
J Pharm Sci; 2009 Apr; 98(4):1587-601. PubMed ID: 18780336
[TBL] [Abstract][Full Text] [Related]
17. Analysis and prediction of absorption profile including hepatic first-pass metabolism of N-methyltyramine, a potent stimulant of gastrin release present in beer, after oral ingestion in rats by gastrointestinal-transit-absorption model.
Kimura T; Iwasaki N; Yokoe JI; Haruta S; Yokoo Y; Ogawara KI; Higaki K
Drug Metab Dispos; 2000 May; 28(5):577-81. PubMed ID: 10772638
[TBL] [Abstract][Full Text] [Related]
18. Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique.
von Richter O; Greiner B; Fromm MF; Fraser R; Omari T; Barclay ML; Dent J; Somogyi AA; Eichelbaum M
Clin Pharmacol Ther; 2001 Sep; 70(3):217-27. PubMed ID: 11557909
[TBL] [Abstract][Full Text] [Related]
19. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
[TBL] [Abstract][Full Text] [Related]
20. Metkephamid and meperidine analgesia after episiotomy.
Bloomfield SS; Barden TP; Mitchell J
Clin Pharmacol Ther; 1983 Aug; 34(2):240-7. PubMed ID: 6872419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
